Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,644 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $331.88 | 3 | $0 (2024) |
| Shire North American Group Inc | $249.60 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $249.60 | 2 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $249.60 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $240.43 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $149.51 | 5 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $134.49 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2018) |
| Theravance Biopharma Inc. | $124.80 | 1 | $0 (2017) |
| Novo Nordisk Inc | $122.39 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $346.69 | 3 | Phathom Pharmaceuticals, Inc. ($134.49) |
| 2023 | $217.74 | 2 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2021 | $238.02 | 2 | Novo Nordisk Inc ($122.39) |
| 2019 | $473.06 | 8 | Janssen Pharmaceuticals, Inc ($149.51) |
| 2018 | $734.33 | 11 | Sunovion Pharmaceuticals Inc. ($249.60) |
| 2017 | $634.49 | 9 | Shire North American Group Inc ($249.60) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $134.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $100.20 | General |
| Category: Respiratory | ||||||
| 05/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $92.74 | General |
| Category: Diabetes | ||||||
| 04/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $115.63 | General |
| Category: DIABETES | ||||||
| 08/11/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $122.39 | General |
| Category: Diabetes | ||||||
| 10/29/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $106.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $112.23 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $104.64 | General |
| Category: Virology | ||||||
| 04/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2018 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $74.40 | General |
| Category: ANTI-VENOM | ||||||
| 07/05/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/31/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 05/30/2018 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Respiratory | ||||||
| 04/13/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Gastroenterology | ||||||
| 04/13/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Gastroenterology | ||||||
| 04/13/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Gastroenterology | ||||||
| 04/13/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 378 | 385 | $405,546 | $44,530 |
| 2022 | 4 | 348 | 352 | $519,899 | $43,452 |
| 2021 | 4 | 522 | 543 | $719,704 | $67,969 |
| 2020 | 5 | 686 | 711 | $861,875 | $66,624 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 197 | 202 | $273,919 | $29,195 | 10.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 88 | 88 | $68,898 | $8,409 | 12.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 31 | $50,474 | $5,544 | 11.0% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 19 | 19 | $8,679 | $1,106 | 12.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 43 | 45 | $3,576 | $275.21 | 7.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 218 | 220 | $414,286 | $33,947 | 8.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 39 | 39 | $79,937 | $7,501 | 9.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 15 | 15 | $18,942 | $1,493 | 7.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 76 | 78 | $6,734 | $510.54 | 7.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 315 | 332 | $537,524 | $49,985 | 9.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 68 | 68 | $127,670 | $12,996 | 10.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 43 | 43 | $46,091 | $4,330 | 9.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 96 | 100 | $8,419 | $658.56 | 7.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 298 | 309 | $542,913 | $44,034 | 8.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 83 | 84 | $231,168 | $15,420 | 6.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 47 | 47 | $56,071 | $4,572 | 8.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 242 | 255 | $21,675 | $1,749 | 8.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 16 | 16 | $10,048 | $849.64 | 8.5% |
About Dr. Ryan Day, MD
Dr. Ryan Day, MD is a Emergency Medicine healthcare provider based in Bethlehem, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2015. The National Provider Identifier (NPI) number assigned to this provider is 1053793703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Day, MD has received a total of $2,644 in payments from pharmaceutical and medical device companies, with $346.69 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,644).
As a Medicare-enrolled provider, Day has provided services to 1,934 Medicare beneficiaries, totaling 1,991 services with total Medicare billing of $222,576. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Bethlehem, PA
- Active Since 06/18/2015
- Last Updated 06/18/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053793703
Products in Payments
- ADVATE (Biological) $249.60
- Trulance (Drug) $249.60
- FARXIGA (Drug) $231.68
- ELIQUIS (Drug) $211.28
- XARELTO (Drug) $149.51
- VOQUEZNA (Drug) $134.49
- SEEBRI (Drug) $124.80
- Utibron (Drug) $124.80
- VIBATIV (Drug) $124.80
- RYBELSUS (Drug) $122.39
- JARDIANCE (Drug) $115.63
- Vascepa (Drug) $112.23
- LIVTENCITY (Drug) $112.00
- Mavyret (Drug) $104.64
- AIRSUPRA (Drug) $100.20
- MOUNJARO (Drug) $92.74
- LINZESS (Drug) $84.74
- CROFAB (Drug) $74.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Bethlehem
Dr. Scott Melanson, Md, MD
Emergency Medicine — Payments: $125,951
John Ashurst, Do, DO
Emergency Medicine — Payments: $25,146
Ashraf Thabet, Do, DO
Emergency Medicine — Payments: $2,259
Dr. Charles Bendas, M.d, M.D
Emergency Medicine — Payments: $1,723
Dr. Samuel Wood, Do, DO
Emergency Medicine — Payments: $1,546
Dr. Kim Kwai, M.d, M.D
Emergency Medicine — Payments: $1,335